Latest revenue
$117.7M
as of 2026-03-31
Latest net income
$-32.5M
as of 2026-03-31
Net margin
-27.6%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $9.4M
- Enterprise value
- $9.4M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $3.32
- 52-wk low
- $0.22
- Beta
- —
- Shares out
- 34.9M
5-year trend
What this company does
ITEM 1 – BUSINESS Corporate History Inotiv, Inc. and its subsidiaries (“we,” “our,” “us,” the “Company,” or “Inotiv”) began operating in 1975 as Bioanalytical Systems, Inc. Bioanalytical Systems, Inc. was incorporated in 1974 and completed an initial public offering in 2000. On March 18, 2021, the Company changed its corporate name from Bioanalytical Systems, Inc. to Inotiv, Inc. Our stock is traded on The Nasdaq Stock Market LLC under the symbol “NOTV.” We are headquartered in West Lafayette, Indiana. Our headquarters mailing address is 2701 Kent Avenue, West Lafayette, Indiana 47906, and the telephone number at that location is (765) 463-4527. Our Internet site is www.inotiv.com. The…
AI summary unavailable — showing raw filing excerpt
Generated from NOTV's filing dated 2025-12-05
Key risks
Table of Contents ITEM 1A – RISK FACTORS Our business is subject to many risks and uncertainties, which may affect our future financial performance or condition. If any of the events or circumstances described below occur, our business and financial performance or condition could be adversely affected, our actual results could differ materially from our expectations and the market value of our stock could decline. The risks and uncertainties discussed below are not the only ones we face. There may be additional risks and uncertainties not currently known to us or that we currently do not believe are material that may adversely affect our business and financial performance. All dollar…
AI summary unavailable — showing raw filing excerpt
Generated from NOTV's filing dated 2025-12-05
Profitability
Gross margin
33.7%
Operating margin
-6.0%
65.8%Net margin
-13.4%
39.5%Return on equity
-50.4%
20.7%Return on assets
-8.9%
35.9%Leverage
Debt / equity
4.67×
30.3%Long-term debt / equity
0.00×
100.0%Debt / assets
82.4%
5.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $117.7M | -5.4% | $-32.5M | -118.4% | -27.6% |
Q4 2025 2025-12-31 | $120.9M | +0.8% | $-28.4M | -2.7% | -23.5% |
Q3 2025 2025-09-30 | $138.1M | +5.9% | $-8.6M | +54.7% | -6.2% |
Q2 2025 2025-06-30 | $130.7M | +23.5% | $-17.6M | +32.6% | -13.5% |
Q1 2025 2025-03-31 | $124.3M | +4.4% | $-14.9M | +69.1% | -12.0% |
Q4 2024 2024-12-31 | $119.9M | -11.5% | $-27.6M | -79.6% | -23.0% |
Q3 2024 2024-09-30 | $130.4M | — | $-18.9M | — | -14.5% |
Q2 2024 2024-06-30 | $105.8M | -32.8% | $-26.1M | -1517.8% | -24.7% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Commercial Physical & Biological Research · SIC 8731
Your notes
Keep private notes on NOTV — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$86.6K
Net activity
−$86.6K
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns NOTV
Institutional value
$809.1K
Total shares held
3.0M
Distinct holders
28
-29 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 643.3K | $175.6K | +213.4K (+49.6%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 601.9K | $164.3K | — | New |
| 3 | Vantage Point Financial LLC | 336.5K | $91.7K | +0 (+0.0%) | No change |
| 4 | BlackRock, Inc. | 331.8K | $90.4K | +7.2K (+2.2%) | Added |
| 5 | JANE STREET GROUP, LLC | 155.7K | $42.4K | +34.0K (+28.0%) | Added |
| 6 | VANGUARD FIDUCIARY TRUST CO | 144.7K | $39.5K | — | New |
| 7 | FIFTH THIRD BANCORP | 140.0K | $38.1K | +100.0K (+250.0%) | Added |
| 8 | Mariner, LLC | 120.2K | $32.8K | +0 (+0.0%) | No change |
| 9 | Bank of New York Mellon Corp | 93.7K | $25.5K | -22.3K (-19.2%) | Trimmed |
| 10 | Invesco Ltd. | 87.1K | $23.7K | +935 (+1.1%) | Added |
| 11 | LPL Financial LLC | 76.8K | $20.9K | +60.2K (+363.1%) | Added |
| 12 | Fi3 FINANCIAL ADVISORS, LLC | 65.7K | $17.9K | +0 (+0.0%) | No change |
| 13 | KPP Advisory Services LLC | 62.1K | $16.9K | -35.5K (-36.4%) | Trimmed |
| 14 | Monument Capital Management | 32.4K | $8.8K | +0 (+0.0%) | No change |
| 15 | Bedel Financial Consulting, Inc. | 14.9K | $4.1K | +0 (+0.0%) | No change |
| 16 | Glenview Trust co | 11.0K | $3.0K | +0 (+0.0%) | No change |
| 17 | Presidio Capital Management, LLC | 10.5K | $2.9K | -5.8K (-35.7%) | Trimmed |
| 18 | ACORN CREEK CAPITAL LLC | 10.0K | $2.7K | -148.8K (-93.7%) | Trimmed |
| 19 | Rockwood Wealth Management, LLC | 10.0K | $2.7K | +0 (+0.0%) | No change |
| 20 | SAPIENT CAPITAL LLC | 10.0K | $2.7K | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once NOTV's latest filing finishes processing.